Medicare Price Cuts on 10 Drugs, Biggest 79% Drop This Year
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesMedicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
When a CEO discloses a sale of 41,600 shares, investors pay attention. This article unpacks the implications, the mec...
Goldman Sachs issued four high-conviction calls across four stocks, pairing two Buy upgrades with two Sell downgrades...
A sizable Hershey share sale by the milton hershey school trust sparks questions about insider activity and stock imp...
A rising AI startup is inviting accredited investors to join a pre-IPO round at $0.85 per share before a March 12 dea...
Owlet's Q4 2025 results reveal a company balancing growth with a path toward profitability. This article disentangles...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
Gas prices in Illinois have jumped, putting the state near the top of the nation’s most expensive lists. This guide e...
Nextpower is set to publish Q4 results amid a swift strategic shift to a solar infrastructure platform. A backlog abo...
Oil’s sharp moves in early 2026 push investors toward stock-based plays that mimic commodity exposure without futures...
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...